Gland Pharma arm Fontenay facility gets 10 observations from France drug regulator

Written By :  Ruchika Sharma
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-12-26 06:00 GMT   |   Update On 2024-12-26 06:00 GMT

TelanganaThrough a recent BSE filing, Gland Pharma has informed that its material subsidiary, Cenexi's Fontenay manufacturing facility gets ten observations from the Agence nationale de sécurité du médicament et des produits de santé (ANSM), France, at the conclusion of a Good Manufacturing Practices (GMP) inspection

The facility was inspected between December 9th to 19th, 2024.

"The said inspection was concluded, and the Facility received an official notification on December 24, 2024, citing 10 (TEN) observations," the Company stated.

"Cenexi is committed to working closely with the ANSM to address the observations and will provide further updates to the exchanges as they become available," it added.
Medical Dialogues team had earlier reported that the United States Food and Drug Administration (US FDA) had concluded an inspection of the Company's Pashamylaram Facility at Hyderabad for Good Manufacturing Practices (GMP) with three 483 Observations.

Gland Pharma was established in 1978 in Hyderabad and has grown over the years from a contract manufacturer of small-volume liquid parenteral products to become growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India, and other markets. It operates primarily under a business-to-business (B2B) model and develops, manufactures, and markets sterile injectables. It has a wide range of injectables, including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions, oncology, and ophthalmic solutions.

Read also: Gland Pharma Vice President (Strategy, Investments & Investor Relations) Ankit Gupta tenders resignation

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News